Constant transitions between dry, warm cabins and cold outdoor air increase immune stress even more

Patients should contact their GP or prescribing clinician if they experience any of the following: Severe or worsening fatigue that: Persists despite implementing lifestyle modifications Progressively worsens rather than improving over time Significantly impairs daily functioning, work performance, or quality of life Is accompanied by weakness, dizziness, or fainting episodes Associated symptoms suggesting potential complications: Severe, persistent abdominal pain, possibly radiating to the back, with or without vomiting (potential signs of pancreatitis requiring urgent medical attention) Pain in the right upper abdomen, fever, or jaundice (potential signs of gallbladder disease) Persistent nausea, vomiting, or diarrhoea leading to dehydration Signs of dehydration: dark urine, dry mouth, reduced urine output, confusion Rapid or irregular heartbeat, chest pain, or shortness of breath Unexplained weight loss exceeding recommended targets (faster than about 0.5-1 kg per week) Mood changes, depression, or anxiety Yellowing of skin or eyes, dark urine, or pale stools (potential liver concerns) For patients with diabetes, particularly those taking insulin or sulfonylureas, symptoms of hypoglycaemia (sweating, shakiness, confusion, irritability) alongside fatigue require prompt attention and potential medication adjustment

GLP-1 access typically requires documented failure of two or more oral diabetes medications plus an HbA1c above 8.0% despite adherence
Sanni and our team at Eastside Bariatric & General Surgery in Snellville, Georgia, offers semaglutide injections to help you achieve your weight loss goals
Jeffrey Maloy email: [email protected] phone: 310-794-9890 office: 243 Hershey Hall website Research Interests Selected Publications Dr
Branch KRH, Dagenais GR, Avezum A et al (2022) Dulaglutide and cardiovascular and heart failure outcomes in patients with and without heart failure: a post-hoc analysis from the REWIND randomized trial